Financials

News Ideas Minds Technicals Forecast

ASPHF fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to ASCENTAGE PHARMA GROUP operating, investing, and financing activities

ASPHF free cash flow for H2 23 is -52.34 M USD. For 2023, ASPHF free cash flow was -121.19 M USD and operating cash flow was -114.66 M USD.

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: USD

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—